{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:47:52Z","timestamp":1778528872304,"version":"3.51.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Hyperosmolar solutions are prescribed in neurosurgery patients to provide satisfactory intraoperative brain relaxation and to lower cerebral injuries related to surgical retractors. Mannitol is traditionally considered as the first-choice solution for brain relaxation in neurosurgery patients. Hypertonic sodium lactate infusion was reported to provide a higher and longer osmotic effect compared to mannitol in severely brain-injured patients and to prevent impaired cerebral energetics related to brain injuries. To date, the clinical effectiveness of hypertonic sodium lactate infusion has never been studied in neurosurgery patients. The hypothesis of the study is that hyperosmolar sodium lactate infusion may provide satisfactory intraoperative brain relaxation in patients undergoing scheduled craniotomy for supratentorial brain tumor resection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and analysis:<\/jats:title>\n            <jats:p>We designed a phase II randomized, controlled, double-blind, single-center pilot trial, and aim to include 50 adult patients scheduled for craniotomy for supratentorial brain tumor resection under general anesthesia. Patients will be randomized to receive either mannitol (conventional group) or hypertonic sodium lactate (intervention group) infusion at the time of skin incision. Brain relaxation (primary outcome) will be assessed immediately after opening the dura by the neurosurgeon blinded to the treatment allocated using a validated 4-point scale. The primary outcome is the proportion of satisfactory brain relaxation, defined as brain relaxation score of 3 or 4.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>This study was approved by the Ethics Committee (Comit\u00e9 de Protection des Personnes Est III) and authorized by the French Health Authority (Agence Nationale de S\u00e9curit\u00e9 des M\u00e9dicaments, Saint-Denis, France). The University Hospital of Besancon is the trial sponsor and the holder of all data and publication rights. Results of the study will be submitted for publication in a peer-review international medical journal and for presentation in abstract (oral or poster) in international peer-reviewed congresses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration:<\/jats:title>\n            <jats:p>The trial is registered with ClinicalTrials.gov (Identifier: NCT04488874, principal investigator: Prof Guillaume Besch, date of registration: July 28, 2020).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000031038","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:01:34Z","timestamp":1665414094000},"page":"e31038","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinical effectiveness of hypertonic sodium lactate infusion for intraoperative brain relaxation in patients undergoing scheduled craniotomy for supratentorial brain tumor resection: A study protocol of a single center double-blind randomized controlled phase II pilot trial"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8975-4754","authenticated-orcid":false,"given":"Guillaume","family":"Besch","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, and EA 3920, University of Franche-Comte, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Parmentier","sequence":"additional","affiliation":[{"name":"Clinical Methodology Center, INSERM CIC 1431, University Hospital of Besancon, and UMR 6249 Chrono Environment, University of Franche-Comte, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Berthier","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Jaeg","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Villeneuve","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fethi","family":"Hammoudi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nans","family":"Scaringella","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Clairet","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University Hospital of Besancon, and Interaction H\u00f4te-Greffon-Tumeur\/Ing\u00e9nierie Cellulaire et G\u00e9nique, University of Bourgogne Franche-Comte (UBFC), INSERM, EFS BFC, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Vettoretti","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Chopard","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Besancon, and EA 481 Neuroscience, IFR 133, University of Bourgogne Franche-Comte, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Thines","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital of Besancon, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, and EA 481 Neuroscience, University of Bourgogne Franche-Comte, Besancon, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Samain","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, and EA 3920, University of Franche-Comte, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Pili-Floury","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, and EA 3920, University of Franche-Comte, Besancon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/bja\/aew096","article-title":"Definition, evaluation, and management of brain relaxation during craniotomy.","volume":"116","author":"Li","year":"2016","journal-title":"Br J Anaesth"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/ACO.0000000000000365","article-title":"Recent trends in the anesthetic management of craniotomy for supratentorial tumor resection.","volume":"29","author":"Gruenbaum","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01402364","article-title":"Self-retaining brain retractor pressure during intracranial procedures.","volume":"85","author":"Rosen\u00f8rn","year":"1987","journal-title":"Acta Neurochir (Wien)"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1179\/016164103771953925","article-title":"Brain retraction injury.","volume":"25","author":"Zhong","year":"2003","journal-title":"Neurol Res"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/CCM.0B013E3181643B41","article-title":"Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure.","volume":"36","author":"Francony","year":"2008","journal-title":"Crit Care Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.1985.63.1.0043","article-title":"Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury.","volume":"63","author":"Mendelow","year":"1985","journal-title":"J Neurosurg"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0749-0704(05)70298-0","article-title":"Osmotherapy. Basic concepts and controversies.","volume":"13","author":"Paczynski","year":"1997","journal-title":"Crit Care Clin"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3171\/2016.6.JNS16537","article-title":"A prospective randomized trial of the optimal dose of mannitol for intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection.","volume":"126","author":"Seo","year":"2017","journal-title":"J Neurosurg"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1378\/chest.122.2.699","article-title":"Management of head trauma.","volume":"122","author":"Marik","year":"2002","journal-title":"Chest"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/00000542-199806000-00023","article-title":"Rebound swelling of astroglial cells exposed to hypertonic mannitol.","volume":"88","author":"McManus","year":"1998","journal-title":"Anesthesiology"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00134-008-1283-5","article-title":"Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients.","volume":"35","author":"Ichai","year":"2009","journal-title":"Intensive Care Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00134-013-2978-9","article-title":"Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe traumatic brain injured patients: a randomized controlled trial.","volume":"39","author":"Ichai","year":"2013","journal-title":"Intensive Care Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncpneuro0883","article-title":"Roles of the cation-chloride cotransporters in neurological disease.","volume":"4","author":"Kahle","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1179\/016164105X25243","article-title":"The role of Na-K-Cl co-transporter in cerebral ischemia.","volume":"27","author":"Chen","year":"2005","journal-title":"Neurol Res"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00134-014-3312-x","article-title":"Hypertonic lactate and the injured brain: facts and the potential for positive clinical implications.","volume":"40","author":"Bouzat","year":"2014","journal-title":"Intensive Care Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00134-013-3203-6","article-title":"Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain.","volume":"40","author":"Bouzat","year":"2014","journal-title":"Intensive Care Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/neu.2015.4057","article-title":"Improvement of neuroenergetics by hypertonic lactate therapy in patients with traumatic brain injury is dependent on baseline cerebral lactate\/pyruvate ratio.","volume":"33","author":"Quintard","year":"2016","journal-title":"J Neurotrauma"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/jcbfm.2009.97","article-title":"Neuroprotective role of lactate after cerebral ischemia.","volume":"29","author":"Berthet","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000343657","article-title":"New evidence of neuroprotection by lactate after transient focal cerebral ischaemia: extended benefit after intracerebroventricular injection and efficacy of intravenous administration.","volume":"34","author":"Berthet","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials.","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/00000542-199306000-00002","article-title":"A prospective, comparative trial of three anesthetics for elective supratentorial craniotomy. Propofol\/fentanyl, isoflurane\/nitrous oxide, and fentanyl\/nitrous oxide.","volume":"78","author":"Todd","year":"1993","journal-title":"Anesthesiology"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.accpm.2018.10.013","article-title":"French legal approach to clinical research.","volume":"37","author":"Toulouse","year":"2018","journal-title":"Anaesth Crit Care Pain Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:40:07Z","timestamp":1746333607000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":22,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031038","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}